Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis (Q78590833)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Yanina Galboiz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Sarah Shapiro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Nitza Lahat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Ariel Miller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

15 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

191-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

Multiple sclerosis: variations on a theme

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Interferon beta in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Matrix metalloproteinases degrade myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

IFN-gamma inhibits AP-1 binding activity in human brain-derived cells through a nitric oxide dependent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Natural killer cells kill tumour cells at a given stage of differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Immune-mediated demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Transcriptional inhibition of stromelysin by interferon-gamma in normal human fibroblasts is mediated by the AP-1 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Expression of several matrix metalloproteinase genes in human monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Immunopathogenesis of multiple sclerosis: the role of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Cytokine-regulated proteases in autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

1 reference

7 January 2021

Lymphocyte migration and multiple sclerosis: relation with disease course and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

The epigenetics of multiple sclerosis: clues to etiology and a rationale for immune therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Changes of serum sICAM-1 and MMP-9 induced by rIFN -1b treatment in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Matrix metalloproteinases and diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of ?2?1 integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900266-7

7 January 2021

10.1016/S0165-5728(02)00266-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458052%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference